民营眼科医疗服务
Search documents
浦银国际证券给予爱尔眼科“买入”评级,全球眼科龙头优势持续强化,目标价格为14.0元
Sou Hu Cai Jing· 2026-01-28 09:06
Group 1 - The core viewpoint of the report is that Aier Eye Hospital (300015.SZ) is rated as "Buy" with a target price of 14.0 yuan [1] - The private ophthalmology medical service market in China has grown to nearly 100 billion yuan, accounting for approximately 40% of the overall ophthalmology medical service market [1] - Aier Eye Hospital is a global leader in ophthalmology medical services, with operations covering multiple markets including China, Europe, and Southeast Asia [1] - The implementation of China's "1+8+N" strategy and the continuous double-digit growth of overseas business are driving the overall revenue increase of the company [1]